Zheng Xing Xing Ye Ri Bao·2026-01-12 09:04Market Overview - The Chinese traditional medicine sector saw a slight increase of 0.11% on January 12, with Wanbangde leading the gains [1] - The Shanghai Composite Index closed at 4165.29, up by 1.09%, while the Shenzhen Component Index closed at 14366.91, up by 1.75% [1] Stock Performance - Wanbangde (002082) closed at 16.56, with a significant increase of 10.03% and a trading volume of 376,100 shares, amounting to 615 million yuan [1] - Zhenbaodao (603567) rose by 4.62% to close at 9.74, with a trading volume of 185,700 shares [1] - Taiji Group (600129) increased by 2.79% to 19.16, despite a decrease in trading volume of 146,600 shares [1] - Renhe Pharmaceutical (000650) and other companies also showed positive growth, with Renhe closing at 6.18, up by 2.15% [1] Capital Flow - The traditional medicine sector experienced a net outflow of 550 million yuan from institutional investors, while retail investors contributed a net inflow of 460 million yuan [2] - The overall capital flow indicates a mixed sentiment, with institutional investors withdrawing funds while retail investors increased their positions [2] Individual Stock Capital Flow - Wanbangde saw a net inflow of 95.22 million yuan from institutional investors, but a net outflow from retail investors of 67.16 million yuan [3] - Other companies like Jianxin Pharmaceutical (002412) and Jilin Aodong (000623) also experienced varying degrees of net inflows and outflows from different investor categories [3]